BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38486106)

  • 21. Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells.
    Sarkar S; Rokad D; Malovic E; Luo J; Harischandra DS; Jin H; Anantharam V; Huang X; Lewis M; Kanthasamy A; Kanthasamy AG
    Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida tropicalis induces NLRP3 inflammasome activation via glycogen metabolism-dependent glycolysis and JAK-STAT1 signaling pathway in myeloid-derived suppressor cells to promote colorectal carcinogenesis.
    Zhang Z; Chen Y; Yin Y; Chen Y; Chen Q; Bing Z; Zheng Y; Hou Y; Shen S; Chen Y; Wang T
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109430. PubMed ID: 36384075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells.
    Erdei J; Tóth A; Balogh E; Nyakundi BB; Bányai E; Ryffel B; Paragh G; Cordero MD; Jeney V
    Oxid Med Cell Longev; 2018; 2018():4310816. PubMed ID: 29743981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome.
    You D; Nie K; Wu X; Weng M; Yang L; Chen Y; Cui J; Wan J
    J Transl Med; 2023 Dec; 21(1):904. PubMed ID: 38082306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance.
    Cheng HY; Hsieh CH; Lin PH; Chen YT; Hsu DS; Tai SK; Chu PY; Yang MH
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.
    Zhang LL; Huang S; Ma XX; Zhang WY; Wang D; Jin SY; Zhang YP; Li Y; Li X
    Free Radic Biol Med; 2016 Aug; 97():531-543. PubMed ID: 27445100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles).
    Xing Y; Cao R; Hu HM
    Cell Death Dis; 2016 Aug; 7(8):e2322. PubMed ID: 27490927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal Stem Cell-Derived Exosomes Ameliorate Diabetic Kidney Disease Through the NLRP3 Signaling Pathway.
    Wang Y; Liu J; Wang H; Lv S; Liu Q; Li S; Yang X; Liu G
    Stem Cells; 2023 Apr; 41(4):368-383. PubMed ID: 36682034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners.
    Leu SY; Tsang YL; Ho LC; Yang CC; Shao AN; Chang CY; Lin HK; Tsai PJ; Sung JM; Tsai YS
    J Endocrinol; 2023 May; 257(2):. PubMed ID: 36799299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis.
    Xia P; Shao YQ; Yu CC; Xie Y; Zhou ZJ
    BMC Immunol; 2022 Aug; 23(1):39. PubMed ID: 35965334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammasome signaling in colorectal cancer.
    Sharma BR; Kanneganti TD
    Transl Res; 2023 Feb; 252():45-52. PubMed ID: 36150688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing complexity of NLRP3 inflammasome regulation.
    Moretti J; Blander JM
    J Leukoc Biol; 2021 Mar; 109(3):561-571. PubMed ID: 32531835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the TXNIP-NLRP3 interaction with PSSM1443 to suppress inflammation in sepsis-induced myocardial dysfunction.
    Wang L; Zhao H; Xu H; Liu X; Chen X; Peng Q; Xiao M
    J Cell Physiol; 2021 Jun; 236(6):4625-4639. PubMed ID: 33452697
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Wang X; Jia Y; Wen L; Mu W; Wu X; Liu T; Liu X; Fang J; Luan Y; Chen P; Gao J; Nguyen KA; Cui J; Zeng G; Lan P; Chen Q; Cheng B; Wang Z
    Cancer Res; 2021 May; 81(10):2745-2759. PubMed ID: 34003774
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo.
    Liang L; Sun W; Wei X; Wang L; Ruan H; Zhang J; Li S; Zhao B; Li M; Cai Z; Huang J
    Phytother Res; 2023 Aug; 37(8):3342-3362. PubMed ID: 36974424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosome-like Nanoparticles from Ginger Rhizomes Inhibited NLRP3 Inflammasome Activation.
    Chen X; Zhou Y; Yu J
    Mol Pharm; 2019 Jun; 16(6):2690-2699. PubMed ID: 31038962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Higashikuni Y; Liu W; Numata G; Tanaka K; Fukuda D; Tanaka Y; Hirata Y; Imamura T; Takimoto E; Komuro I; Sata M
    Circulation; 2023 Jan; 147(4):338-355. PubMed ID: 36440584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of NLRP3 inflammasome promotes the proliferation and migration of esophageal squamous cell carcinoma.
    Yu S; Yin JJ; Miao JX; Li SG; Huang CZ; Huang N; Fan TL; Li XN; Wang YH; Han SN; Zhang LR
    Oncol Rep; 2020 Apr; 43(4):1113-1124. PubMed ID: 32323780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages.
    Duan Y; Wang J; Cai J; Kelley N; He Y
    J Biol Chem; 2022 Dec; 298(12):102717. PubMed ID: 36403854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.